Finance
Markets
No recent trading data. The last price we hold for LLY is from Jun 3 (48 days ago). This symbol may be delisted, renamed, or halted — the figures below reflect its last active session, not the current market.

LLY

stock Healthcare Drug Manufacturers - General
Lilly (Eli)
$1,082.87 +18.72 (+1.76%) Delayed · quoted 47d ago
Healthy 76% Climbing

What the indicators say

Bullish 5 of 5 trend signals bullish
Momentum · RSI 14 Leaning bullish
62
0oversold 30overbought 70100

RSI 62 — firm momentum, not yet overbought.

EMA 21 $1035.35
Above
Near-term trend is up
SMA 50 $964.36
Above
Medium-term trend is up
SMA 200 $943.36
Above
Long-term trend is up
50 / 200-day
Golden cross
50-day above the 200-day — bullish
Supertrend $1021.69
Uptrend
Price is holding above the Supertrend band — bullish

A mechanical reading of the chart’s indicators — not investment advice.

Key statsas of Jun 3

The day open and close within the day's range
Low $1,053.51 High $1,093.28
Open
$1,082.87
+1.76%
Close
$1,082.87
+1.76%
52-week range where the price sits across its year
52w low $623.78 52w high $1,149.10
Current
$1,082.87
Prev close
$1,064.15
Volume 0.64× the 3-month average
0 avg 2× avg
Today
1.97M
3-mo avg
3.07M

Earningscalendar synced from Yahoo 57d ago

Most recent
Apr 3082 days ago
Next expected
Aug 5in 15 days

Recent earnings dates

  • Apr 30 82 days ago
  • Feb 4 167 days ago
  • Oct 30, 2025 264 days ago
  • Aug 7, 2025 348 days ago

Past earnings dates come from LLY’s 8-K item 2.02 filings; the next date is Yahoo’s when available, otherwise estimated from the recent reporting cadence.

Fundamentalssynced from SEC 53d ago

Strong

Across the nine graded ratios (FY2025 balance-sheet figures, P/E on TTM through Mar 2026 earnings, against the latest price), LLY’s fundamentals read as strong overall.

P/E ratio Fair
38.5x

At 38.5x, investors are paying up; a fair amount of future growth is already in the price.

Share price divided by earnings per share: what you pay for each $1 of yearly profit. Roughly 15 to 25 is typical, above 40 is richly priced, and negative means the company is losing money.

Dividend yield Fair
0.58%

A 0.6% yield is modest: a small income on top of whatever the share price does.

The yearly dividend as a percent of the share price: the cash income each share pays out. Around 2 to 6% is healthy; above roughly 8% often signals the payout may be cut.

Profit margin Strong
31.7%

A 31.7% margin is strong; the company keeps a healthy slice of every revenue dollar.

The share of revenue left as profit once every cost is paid. Above 15% is strong; below 5% leaves little cushion against a bad year.

Return on equity Strong
77.8%

A 77.8% return on equity is strong; the company compounds owners' capital well.

Profit earned on each dollar of shareholder equity: how well the company compounds its owners' capital. Above 15% is strong.

Return on assets Strong
18.4%

A 18.4% return on assets is strong; the company squeezes good profit from its assets.

Profit earned on each dollar of assets: how efficiently the whole asset base is used. Above 8% is strong.

Debt-to-equity No data
—

Not enough data to compute debt-to-equity.

Total liabilities divided by shareholder equity: how heavily the company leans on borrowing. Below 1 is conservative; above 2 is highly leveraged.

Current ratio Strong
1.58

At 1.58, short-term assets comfortably cover short-term bills.

Current assets divided by current liabilities: whether short-term resources cover short-term bills. Above 1.5 is comfortable; below 1 is tight.

Revenue growth Strong
+44.7%

Revenue grew 44.7% from the prior year: strong top-line expansion.

Change in annual revenue from the prior fiscal year: whether the top line is expanding. Above 10% is strong growth; below 0 means revenue is shrinking.

Earnings growth Strong
+94.9%

Net income grew 94.9% from the prior year: strong profit expansion.

Change in annual net income from the prior fiscal year: whether profit is expanding. Above 10% is strong; below 0 means profit is falling.

Financialssynced from SEC 53d ago

FY2021FY2022FY2023FY2024FY2025
Revenue $28.3B$28.5B$34.1B$45.0B$65.2B
Net income $5.6B$6.2B$5.2B$10.6B$20.6B
Diluted EPS $6.12$6.90$5.80$11.71$22.95
Dividend / share $3.53$4.07$4.69$5.40$6.23
Total assets $48.8B$49.5B$64.0B$78.7B$112.5B
Total liabilities —————
Shareholder equity $9.0B$10.6B$10.8B$14.3B$26.5B

Leadershipsynced from SEC 59d ago

  • Ricks David A President, Chair, and CEO · Director
  • Montarce Lucas EVP & CFO
  • Brown Adrienne S EVP, President LLY Imm
  • Custer Kenneth L. EVP & President, Card Met Hlth
  • Dozier Eric EVP, Chief People Officer
  • Rau Diogo EVP & CIDO
  • Skovronsky Daniel EVP, CS&PO & Pres. LRL
  • Van Naarden Jacob EVP,Pres LLY Oncology&HdCorpBD
  • Yuffa Ilya EVP&Pres, LLY USA&Global Capab
  • Zakrowski Donald A SVP, Finance, & CAO
  • Alvarez Ralph Director
  • Fyrwald J Erik Director
  • Luciano Juan R Director
  • Sulzberger Gabrielle Director

Officers and board are drawn from LLY’s recent SEC ownership filings (Forms 3, 4 and 5).

Recent leadership changes

Notable recent eventspast year

  • Apr 30 +9.8% one-day move
  • Mar 17 −5.9% one-day move
  • Feb 5 −7.8% one-day move
  • Feb 4 +10.3% one-day move
  • Dec 31, 2025 FY2025 net income +95% YoY
  • Dec 31, 2025 FY2025 revenue +45% YoY
  • Nov 21, 2025 Officer or director change reported in an 8-K
  • Oct 1, 2025 +8.2% one-day move
  • Sep 30, 2025 +5.0% one-day move
  • Aug 7, 2025 New 6-month low (-31% off peak)
  • Aug 7, 2025 −14.1% one-day move

Large daily moves, new 6-month lows, year-over-year fundamentals swings, and reported leadership changes — pulled from the data this app already holds, never investment advice.

Dividendssynced from Yahoo 52d ago

Pays quarterly Strong
2025 total
$6.00
2026 so far
$3.462 payments
2026 projected
$6.92+15.3% vs 2025

Projection scales LLY’s declared payments so far this year up to the inferred cadence, then compares to last year’s total. Between payouts it is an estimate, not a guarantee.

Payment history

  • May 15 $1.73
  • Feb 13 $1.73
  • Nov 14, 2025 $1.50
  • Aug 15, 2025 $1.50
  • May 16, 2025 $1.50
  • Feb 14, 2025 $1.50
  • Nov 15, 2024 $1.30
  • Aug 15, 2024 $1.30
  • May 15, 2024 $1.30
  • Feb 14, 2024 $1.30
  • Nov 14, 2023 $1.13
  • Aug 14, 2023 $1.13
  • May 12, 2023 $1.13
  • Feb 14, 2023 $1.13
  • Nov 14, 2022 $0.98
  • Aug 12, 2022 $0.98
  • May 13, 2022 $0.98
  • Feb 14, 2022 $0.98
  • Nov 12, 2021 $0.85
  • Aug 12, 2021 $0.85

Recent SEC filingssynced from SEC 53d ago

© 2026 Isaac Bythewood · Some rights reserved